Home/Kovina Therapeutics/Elliot Androphy, M.D.

EA

Elliot Androphy, M.D.

Founder, Chief Scientific Officer

Kovina Therapeutics

Therapeutic Areas

Oncology Infectious Disease

Kovina Therapeutics Pipeline

Drug	Indication	Phase
HPV E6 Inhibitor Program	HPV-driven Cancers (e.g., Cervical, Oropharyngeal)	Preclinical

Leadership Team at Kovina Therapeutics

Kristin Sherman

Zhijian Lu, Ph.D.

Founder, Vice President, Medicinal Chemistry

Colleen Beeler, CPA

Vice President, Finance

Paddy Shivanand, Ph.D.

Vice President, CMC

View full Kovina Therapeutics profile